E.J.L. ExAct SRL
The score of E.J.L. ExAct shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -23 % Total assets -24 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
E.J.L. ExAct's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Jun 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 22 Jul 2024
- Year ended 31 Dec 2022filed on 24 Jul 2023
- Year ended 31 Dec 2021filed on 05 Jul 2022
E.J.L. ExAct's financial analysis
- Solvency100.0%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of E.J.L. ExAct
E.J.L. ExAct's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0846.380.626
- VAT number
- BE0846380626
- Peppol
- Registered · 0208:0846380626 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Jun 2012
- Registered office
- 8400 Ostend
- Latest accounts
- 2025 · filed on 26 Jun 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
E.J.L. ExAct (SRL) has been based in Ostend since 2012, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of 2,218 € and equity of 59,234 €; its revenue is not published. Its solvency stands at 100.0%, above the median of its sector (56.0%).
Companies similar to E.J.L. ExAct
Companies in the same business, of comparable size and area, outside its group.
- Evarmed Manufacture of basic pharmaceutical products Diepenbeek · balance sheet 51,346 €
- Premium Pharma Retail Manufacture of basic pharmaceutical products Molenbeek-Saint-Jean · balance sheet 34,216 €
- Regen Consulting Manufacture of basic pharmaceutical products Chaumont-Gistoux · balance sheet 104,347 €
- Calluna Pharma Manufacture of basic pharmaceutical products Hoogstraten · balance sheet 73,235 €
- Pharmacie Courouble Manufacture of basic pharmaceutical products Schaerbeek · balance sheet 129,672 €
- MC Pharma Manufacture of basic pharmaceutical products Beaumont · balance sheet 28,699 €
- Chris Pharma Works Manufacture of basic pharmaceutical products Profondeville · balance sheet 24,086 €
- Estrella Clinical Research Manufacture of basic pharmaceutical products Herentals · balance sheet 41,482 €
Frequently asked questions about E.J.L. ExAct
What is the revenue of E.J.L. ExAct?
E.J.L. ExAct files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of E.J.L. ExAct?
In Belgium, the VAT number is the company number prefixed with BE: BE0846380626 for E.J.L. ExAct, if the company is VAT-registered. Its company number (CBE) is 0846.380.626.
Where is the registered office of E.J.L. ExAct?
According to the CBE register, the registered office of E.J.L. ExAct is in 8400 Ostend.
What is the equity of E.J.L. ExAct?
At the close of the 2025 financial year, the equity of E.J.L. ExAct amounts to 59,234 €, a solvency of 100.0% of total assets.
Who manages E.J.L. ExAct?
The register lists 1 active mandates at E.J.L. ExAct. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of E.J.L. ExAct
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →